Eli Lilly, Regeneron, Gilead: What The Vaccine Means For Covid-19 Treatment Stocks |
November 17, 2020 | November 2020 Bond Updates |
Pfizer’s surprisingly strong initial Covid-19 vaccine efficacy data that came out last week probably marks the beginning of the end of the Covid-19 pandemic. While this is very positive for the economy and the broader stock market, what does it mean for companies that sell or are developing... |
View more at: https://www.forbes.com/sites/greatspeculations/2020/11/16/eli-lilly-regeneron-gilead-what-the-vaccine-means-for-covid-19-treatment-stocks/ |
Related News |
|